Harnessing AI for brain health: lab to market to society

Bringing Artificial Intelligence home for a better care of amyotrophic lateral sclerosis and multiple sclerosis

13 November 2024 from 16:00-17:45 CET at Brain Innovation Days

The EGG Brussels, Belgium

Artificial intelligence (AI) in healthcare is a booming field: the development of computer programs and systems able to emulate tasks normally requiring human intelligence such as recognizing patterns, taking decisions, evaluating and predicting is set to revolutionize the care of people with a brain disease.

If clinicians could provide personalised care to people living with Multiple Sclerosis (MS) and Amyotrophic Lateral Sclerosis (ALS) remotely, via an app, what would the future look like? The future is already here. BRAINTEASER (Bringing Artificial Intelligence home for a better care of amyotrophic lateral sclerosis and multiple sclerosis) is an EU-funded project seeking to exploit the value of big data (large clinical datasets, patient-generated data from wearables and air pollution data from sensors) to advance remote monitoring and clinical decision making in MS and ALS. Through an AI-based model, BRAINTEASER aims to promote fast, accurate feedback between patients and clinicians.

BRAINTEASER liaison activities aim to keep the project aligned with relevant EU and global projects and initiatives and generate synergies to maximise impact. In this context, an impact and exploitation workshop will be held at 2024 Brain Innovation Days (BIDays) and feature BRAINTEASER clinical app to shed light on AI excellence thriving from the lab to the market to the benefit of people living with a brain condition.

Register now for remote attendance

Join us in Brussels, 13-14 November 2024